Literature DB >> 3941854

The dorsalis pedis free flap: technique of elevation, foot closure, and flap application.

R M Zuker, R T Manktelow.   

Abstract

The dorsalis pedis free flap is an excellent reconstructive tool for thin remote mucosal defects, for heel and hand defects where innervation is critical, and as an osteocutaneous flap with unique application to mandibular and floor of mouth reconstruction. The major criticism with this flap is related to its uncertain vascularity and the donor defect. We have found in our series of 45 cases that the vascular anatomy is exceedingly reliable. Problems with the donor defects are all related to technique. With care in flap elevation and foot closure, which we describe in detail, an acceptable donor site with minimal complications can be achieved. The clinical applications of this flap are illustrated by three case reports. Our experience with the donor site has not been problem-free. However, we do believe that with meticulous technique primary healing will occur without functional disability and with minimal cosmetic deformity.

Entities:  

Mesh:

Year:  1986        PMID: 3941854     DOI: 10.1097/00006534-198601000-00014

Source DB:  PubMed          Journal:  Plast Reconstr Surg        ISSN: 0032-1052            Impact factor:   4.730


  3 in total

1.  Microsurgical soft-tissue hand reconstruction: an algorithm for selection of the best procedure.

Authors:  Ricardo Horta; Pedro Silva; António Costa-Ferreira; José Manuel Amarante; Alvaro Silva
Journal:  J Hand Microsurg       Date:  2011-06-24

Review 2.  Choice of osseous and osteocutaneous flaps for mandibular reconstruction.

Authors:  Akihiko Takushima; Kiyonori Harii; Hirotaka Asato; Akira Momosawa; Mutsumi Okazaki; Takashi Nakatsuka
Journal:  Int J Clin Oncol       Date:  2005-08       Impact factor: 3.402

3.  Reconstruction of the anterior lower third of the face using a composite pectoralis major free flap.

Authors:  D R Gateley; A L Moss; P Blenkinsopp
Journal:  J R Soc Med       Date:  1993-12       Impact factor: 18.000

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.